Proteolytic processing of endogenous and recombinant beta 4 integrin subunit.

The aim of this study was to investigate whether the beta 4 integrin subunit is proteolytically processed in cultured cells and tissues. Researchers wanted to determine if this cleavage occurs in epithelial cells and whether it is tissue-specific. The specific problem addressed was the lack of evidence for proteolytic processing of the beta 4 subunit in vivo. The motivation for this research was to understand how integrin function might be modulated through proteolysis. The study sought to clarify whether cleavage occurs in different tissues and what the resulting fragments might indicate about function. Researchers also aimed to identify the enzymes responsible for cleavage and the sites of proteolysis. This could help explain how integrin activity is regulated in epithelial cells. The findings could contribute to understanding how cell-matrix interactions are controlled in different tissues.

The researchers used cultured epithelial cells and CHO cells transfected with beta 4 cDNA to study proteolytic processing. Immunoprecipitation experiments were performed to detect cleavage of the cytoplasmic domain. In vitro assays with purified calpain were used to test whether this enzyme could cleave beta 4. Immunoblotting was used to analyze the size and pattern of cleavage products in cultured cells. Antibodies specific to the COOH-terminus of beta 4 were used to detect fragments. The same approach was applied to cells transfected with mutant cDNA lacking the epitope. Tissue sections from human skin and cornea were stained with antibodies to the ectodomain and cytoplasmic domain of beta 4. The staining patterns were compared to determine whether cleavage occurs in vivo.

The cytoplasmic domain of beta 4 was found to be cleavable by a calcium-dependent protease in cellular extracts. In vitro calpain assays showed cleavage at two distinct sites, producing 165 and 130 kD fragments. Immunoblotting in cultured epithelial cells revealed 70 kD and multiple fragments between 185 and 115 kD. These fragments were also detected in CHO cells transfected with full-length beta 4 cDNA. No fragments were detected in control or mutant-transfected cells. The data suggest that both intracellular and extracellular domains of beta 4 are proteolytically processed. In human skin sections, distinct staining patterns with ectodomain and cytoplasmic antibodies indicated cleavage in vivo. In contrast, corneal sections showed no detectable cleavage of the beta 4 subunit.

The study provides evidence that the beta 4 integrin subunit is proteolytically processed in cultured cells and tissues. Cleavage occurs at two sites in the cytoplasmic domain and affects both intracellular and extracellular regions. The cleavage pattern was observed in cultured epithelial cells and in human skin sections. However, no cleavage was detected in the cornea, suggesting tissue-specific regulation. These findings suggest that proteolytic processing may modulate the function of alpha 6 beta 4 integrin. The results indicate that calpain is a likely enzyme involved in the cleavage process. The tissue-specific nature of cleavage implies that integrin activity may be regulated differently in various tissues. The authors propose that this cleavage could serve as a mechanism to fine-tune integrin function in epithelial cells.